These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 18008262)
21. [Clinical and psychological factors influencing the efficacy of botulinum toxin in the treatment of hemifacial spasm and blepharospasm]. Burbaud P; Arnaud A; Burbaud A; Lagueny A J Fr Ophtalmol; 1995; 18(12):751-7. PubMed ID: 8745707 [TBL] [Abstract][Full Text] [Related]
22. [Hemifacial spasm]. Krystkowiak P Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S142-5. PubMed ID: 19576481 [TBL] [Abstract][Full Text] [Related]
23. Botulinum toxin-A for the treatment of hemifacial spasm. Cuevas C; Madrazo I; Magallón E; Zamorano C; Neri G; Reyes E Arch Med Res; 1995; 26(4):405-8. PubMed ID: 8555735 [TBL] [Abstract][Full Text] [Related]
24. Effects of botulinum toxin-B (BTX-B) injections for hemifacial spasm. Tousi B; Perumal JS; Ahuja K; Ahmed A; Subramanian T Parkinsonism Relat Disord; 2004 Oct; 10(7):455-6. PubMed ID: 15465407 [No Abstract] [Full Text] [Related]
25. Botulinum toxin injections for the treatment of hemifacial spasm over 16 years. Sorgun MH; Yilmaz R; Akin YA; Mercan FN; Akbostanci MC J Clin Neurosci; 2015 Aug; 22(8):1319-25. PubMed ID: 26100157 [TBL] [Abstract][Full Text] [Related]
26. The impact of long-term botulinum toxin injections on symptom severity in patients with spasmodic dysphonia. Damrose JF; Goldman SN; Groessl EJ; Orloff LA J Voice; 2004 Sep; 18(3):415-22. PubMed ID: 15331116 [TBL] [Abstract][Full Text] [Related]
27. Botulinum toxin type B (Myobloc) in subjects with hemifacial spasm: results from an open-label, dose-escalation safety study. Trosch RM; Adler CH; Pappert EJ Mov Disord; 2007 Jul; 22(9):1258-64. PubMed ID: 17588242 [TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of botulinum toxin therapy in otorhinolaryngology: experience from 1,000 treatments. Helmstaedter V; Wittekindt C; Huttenbrink KB; Guntinas-Lichius O Laryngoscope; 2008 May; 118(5):790-6. PubMed ID: 18300708 [TBL] [Abstract][Full Text] [Related]
29. Treatment outcome correlates with knowledge of disease in hemifacial spasm. Tan EK; Hameed S; Fook-Chong S; Hussein K; Lum SY; Chan LL Clin Neurol Neurosurg; 2008 Sep; 110(8):813-7. PubMed ID: 18583029 [TBL] [Abstract][Full Text] [Related]
33. The Babinski-2 sign in hemifacial spasm. Pawlowski M; Gess B; Evers S Mov Disord; 2013 Aug; 28(9):1298-300. PubMed ID: 23637014 [TBL] [Abstract][Full Text] [Related]
34. The validation of the disease-specific questionnaire for health-related quality of life in Thai patients with hemifacial spasm. Setthawatcharawanich S; Aui-aree N; Limapichart K; Satirapunya P; Phabphal K J Med Assoc Thai; 2008 Nov; 91(11):1691-7. PubMed ID: 19127791 [TBL] [Abstract][Full Text] [Related]
35. A new grading system for assessing orbicularis muscle function. Rahman R; Berry-Brincat A; Thaller VT Eye (Lond); 2003 Jul; 17(5):610-2. PubMed ID: 12855968 [TBL] [Abstract][Full Text] [Related]
36. [Safety and efficacy of botulinum toxin in hemifacial spasm]. Mazlout H; Kamoun Gargouri H; Triki W; Kéfi S; Brour J; El Afrit MA; Chéour M; Kraiem A J Fr Ophtalmol; 2013 Mar; 36(3):242-6. PubMed ID: 23270989 [TBL] [Abstract][Full Text] [Related]
37. Effect of botulinum neurotoxin treatment in the lateral spread monitoring of microvascular decompression for hemifacial spasm. Habeych ME; Shah AC; Nikonow TN; Balzer JR; Crammond DJ; Thirumala PD; Kassam A; Horowitz M Muscle Nerve; 2011 Oct; 44(4):518-24. PubMed ID: 21826681 [TBL] [Abstract][Full Text] [Related]
38. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia. Stong BC; DelGaudio JM; Hapner ER; Johns MM Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):793-5. PubMed ID: 16172357 [TBL] [Abstract][Full Text] [Related]